Tolmar is committed to the development, approval, and commercialization of specialty pharmaceutical products dedicated to advancing patient care. We are focused on the needs of today, with a vision of tomorrow that drives our dedication to the community and the patients it serves.
Tolmar’s state-of-the-art product development and manufacturing facilities are based in Colorado and commercial operations are based in Illinois. To learn more visit www.tolmar.com
Fensolvi® (leuprolide acetate) is a 6-month, subcutaneous injection, enabled by a unique in-situ polymeric gel extended delivery system. Fensolvi® is manufactured by Tolmar, a specialty pharmaceutical company with an established commercial presence across the United States. To learn more visit www.Fensolvi.com